Sunshine Biopharma, Inc. (SBFM)
| Market Cap | 32.50M |
| Revenue (ttm) | 171,321 |
| Net Income (ttm) | -14.19M |
| Shares Out | 17.19M |
| EPS (ttm) | -2.21 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 617,646 |
| Open | 1.92 |
| Previous Close | 1.97 |
| Day's Range | 1.85 - 2.03 |
| 52-Week Range | 1.51 - 9.87 |
| Beta | -2.26 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About SBFM
Sunshine Biopharma, Inc., a pharmaceutical and nutritional supplement company, focuses on the research and development of anticancer drugs. The company is developing Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin to treat leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, liver, and other forms of cancers, as well as kills multidrug resistant cancer cells, including pancreatic cancer, breast cancer, small-cell lung cancer, and uterine sarcoma cells; and SBFM-PL4, an anti-coronavirus treatmen...
Financial Performance
In 2020, SBFM's revenue was $71,410, an increase of 238.10% compared to the previous year's $21,121. Losses were -$2.78 million, 67.7% more than in 2019.
Financial StatementsNews
Sunshine Biopharma: An Opportunity Knocking?
Investors with a very high appetite for risk and seeking ultra-high-growth stocks can find potential opportunities within the pharma and biotech domain. Investing in development-stage biopharma companie...
Sunshine Biopharma, Inc. Announces Closing of $19.5 Million Private Placement Priced At-the-Market
MONTREAL, April 28, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development ...
Aegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for ...
NEW YORK, NY / ACCESSWIRE / April 28, 2022 / Aegis Capital Corp. acted as Exclusive Placement Agent on a $19.5 Million Private Placement Priced At-the-Market for Sunshine Biopharma Inc. (NASDAQ:SBFM) Ab...
Multiple Promising Treatments Accentuate the Bull Case for Sunshine Biopharma
SBFM stock is trading at a surprisingly low price, considering Sunshine Biopharma's demonstrably positive clinical results. The post Multiple Promising Treatments Accentuate the Bull Case for Sunshine B...
Sunshine Biopharma, Inc. Announces Pricing of $19.5 Million Private Placement Priced At-the-Market
MONTREAL, April 26, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development ...
Why Is Sunshine Biopharma (SBFM) Stock Up Today?
Today, investors in Sunshine Biopharma and SBFM stock are getting a huge boost from news that the company filed a patent for a key drug. The post Why Is Sunshine Biopharma (SBFM) Stock Up Today?
Why Sunshine Biopharma Stock Is Surging
Sunshine Biopharma Inc (NASDAQ: SBFM) shares are trading higher Monday after the company announced it filed a United States provisional patent application covering the recently communicated mRNA molecul...
Sunshine Biopharma Files Patent Application Covering Recently Announced mRNA Molecules Found To Be Effective At Destr...
MONTREAL, April 25, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”), a pharmaceutical company focused on the research, development and commercialization of oncology and an...
Blockbuster Clinical Results Shine a Positive Light on Sunshine Biopharma
An SEC filing may have deterred some traders from holding SBFM stock. However, a closer look at the facts should clear up any confusion.
5 Stocks Halted In Tuesday's Session
A circuit breaker is an automatic, temporary trading halt on specific securities when the underlying stock is experiencing times of high volatility. It is a measure to help restore and bring order to th...
Why Is Sunshine Biopharma (SBFM) Stock Down 30% Today?
Sunshine Biopharma's winning streak is likely finished due to confusion over an announcement. Here's why SBFM stock is down today.
Why Sunshine Biopharma Stock Is Falling Today
Sunshine Biopharma Inc (NASDAQ: SBFM) shares are trading lower Friday morning after the company announced a common stock offering. Sunshine Biopharma plans to offer on a resale basis an aggregate of 7,...
What's Going On With Sunshine Biopharma Stock Today?
Sunshine Biopharma Inc (NASDAQ: SBFM) is trading higher Wednesday on continued momentum after the company on Tuesday announced that two of its designed mRNA molecules are effective at destroying cancer ...
Trading Penny Stocks on April 6th, MOBQ Stock Pushes Up
Here's what you need to know about trading penny stocks on April 6th The post Trading Penny Stocks on April 6th, MOBQ Stock Pushes Up appeared first on Penny Stocks to Buy, Picks, News and Information |...
Sunshine Biopharma Stock Triples on Positive mRNA Cancer Treatment Results
Montreal-based Sunshine Biopharma stock tripled to $6.53 on Tuesday after revealing that two of its newly designed mRNA molecules are effective in destroying cancer cells. The post Sunshine Biopharma St...
Sunshine Biopharma Shares Are Soaring: Here's Why
Sunshine Biopharma Inc (NASDAQ: SBFM) shares are trading significantly higher Tuesday after the company announced that two of its designed mRNA molecules are effective at destroying cancer cells grown i...
Trading Penny Stocks, April 5th, SBFM and TWTR Explode
Here's what you need to know about trading penny stocks on April 5th The post Trading Penny Stocks, April 5th, SBFM and TWTR Explode appeared first on Penny Stocks to Buy, Picks, News and Information | ...
Best Penny Stocks Today: Why SBFM Stock Is Moving 175%+
Shares of SBFM stock are on the move and here's why. The post Best Penny Stocks Today: Why SBFM Stock Is Moving 175%+ appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Sunshine Biopharma's Newly Designed mRNA Molecules Prove Effective Against Multidrug Resistant Cancer Cells
A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments A Potential Multi-Billion Dollar Global Market Opportunity for Cancer Treatments
Aegis Capital Corp. acted as Exclusive Placement Agent on an $8 Million Private Placement for Sunshine Biopharma Inc....
NEW YORK, NY / ACCESSWIRE / March 15, 2022 / Aegis Capital Corp. acted as Exclusive Placement Agent on an $8 Million Private Placement for Sunshine Biopharma Inc. (NASDAQ:SBFM) About Sunshine Biopharma,...
Sunshine Biopharma, Inc. Announces Closing of $8.0 Million Private Placement Priced At-the-Market
MONTREAL, March 14, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development ...
Sunshine Biopharma, Inc. Announces Pricing of $8.0 Million Private Placement Priced At-the-Market
MONTREAL, March 10, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development ...
SBFM Stock Alert: 7 Things to Know as Sunshine Biopharma Skyrockets
Today, investors in Sunshine Biopharma and SBFM stock are seeing impressive gains. The stock is surging more than 160% on intense interest.
Sunshine Biopharma Expands Anti-Coronavirus Drug Development Program By Signing A Collaboration Agreement With The Un...
MONTREAL, Feb. 25, 2022 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (NASDAQ: “SBFM” and SBFMW) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development and ...
Aegis Capital Corp. acted as Sole Bookrunner on an Uplist of an $8 Million Underwritten Public Offering for Sunshine ...
NEW YORK, NY / ACCESSWIRE / February 17, 2022 / Aegis Capital Corp. acted as Sole Bookrunner on an Uplist of an $8 Million Underwritten Public Offering for Sunshine Biopharma Inc. (NASDAQ:SBFM; SBFMW) A...